Beit Jala Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Beit Jala Pharmaceutical has a total shareholder equity of JOD14.0M and total debt of JOD641.8K, which brings its debt-to-equity ratio to 4.6%. Its total assets and total liabilities are JOD18.1M and JOD4.1M respectively. Beit Jala Pharmaceutical's EBIT is JOD1.6M making its interest coverage ratio 18.6. It has cash and short-term investments of JOD521.6K.
Key information
4.6%
Debt to equity ratio
د.أ641.82k
Debt
| Interest coverage ratio | 18.6x |
| Cash | د.أ521.63k |
| Equity | د.أ14.02m |
| Total liabilities | د.أ4.09m |
| Total assets | د.أ18.11m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BJP's short term assets (JOD9.5M) exceed its short term liabilities (JOD2.5M).
Long Term Liabilities: BJP's short term assets (JOD9.5M) exceed its long term liabilities (JOD1.6M).
Debt to Equity History and Analysis
Debt Level: BJP's net debt to equity ratio (0.9%) is considered satisfactory.
Reducing Debt: BJP's debt to equity ratio has reduced from 16.7% to 4.6% over the past 5 years.
Debt Coverage: BJP's debt is well covered by operating cash flow (259.4%).
Interest Coverage: BJP's interest payments on its debt are well covered by EBIT (18.6x coverage).